156 related articles for article (PubMed ID: 15860046)
1. Antithrombotic effect of a new nitric oxide donor (LA419) on experimental thrombogenesis.
Hernandez MR; Tonda R; Arderiu G; Pino M; Serradell M; Escolar G
Eur J Clin Invest; 2005 May; 35(5):337-42. PubMed ID: 15860046
[TBL] [Abstract][Full Text] [Related]
2. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
Vilahur G; Pena E; Padró T; Badimon L
Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of effects of rofecoxib on platelet function in an in vitro model of thrombosis with circulating human blood.
Hernandez MR; Tonda R; Pino M; Serradell M; Arderiu G; Escolar G
Eur J Clin Invest; 2004 Apr; 34(4):297-302. PubMed ID: 15086362
[TBL] [Abstract][Full Text] [Related]
4. A novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjects.
Zafar MU; Vilahur G; Choi BG; Ibanez B; Viles-Gonzalez JF; Salas E; Badimon JJ
J Thromb Haemost; 2007 Jun; 5(6):1195-200. PubMed ID: 17389007
[TBL] [Abstract][Full Text] [Related]
5. A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis.
Bossavy JP; Sakariassen KS; Barret A; Boneu B; Cadroy Y
Thromb Haemost; 1998 Jan; 79(1):162-8. PubMed ID: 9459343
[TBL] [Abstract][Full Text] [Related]
6. Proteomic signature of thrombin-activated platelets after in vivo nitric oxide-donor treatment: coordinated inhibition of signaling (phosphatidylinositol 3-kinase-γ, 14-3-3ζ, and growth factor receptor-bound protein 2) and cytoskeleton protein translocation.
Peña E; Padro T; Molins B; Vilahur G; Badimon L
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2560-9. PubMed ID: 21836071
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations.
Buccellati C; Sala A; Rossoni G; Capra V; Rovati GE; Di Gennaro A; Folco G; Colli S; Casagrande C
J Pharmacol Exp Ther; 2006 May; 317(2):830-7. PubMed ID: 16399881
[TBL] [Abstract][Full Text] [Related]
8. Effects on primary haemostasis of an anti-inflammatory agent with 5-lipoxygenase and cyclooxygenase inhibitory activity.
Hernandez MR; Tonda R; Pedreño J; Salas E; Arderiu G; Pino M; Serradell M; Escolar G
J Cardiovasc Med (Hagerstown); 2006 Dec; 7(12):859-65. PubMed ID: 17122671
[TBL] [Abstract][Full Text] [Related]
9. LA419, a novel nitric oxide donor, prevents pathological cardiac remodeling in pressure-overloaded rats via endothelial nitric oxide synthase pathway regulation.
Ruiz-Hurtado G; Fernández-Velasco M; Mourelle M; Delgado C
Hypertension; 2007 Dec; 50(6):1049-56. PubMed ID: 17984372
[TBL] [Abstract][Full Text] [Related]
10. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P
Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098
[TBL] [Abstract][Full Text] [Related]
11. A new nitrate derivative of piperazine: its influence on platelet activity.
Kostka B; Sikora J; Para J; Krajewska U; Korzycka L
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):151-6. PubMed ID: 17287632
[TBL] [Abstract][Full Text] [Related]
12. A novel anti-ischemic nitric oxide donor inhibits thrombosis without modifying haemodynamic parameters.
Vilahur G; Segalés E; Casaní L; Badimon L
Thromb Haemost; 2004 May; 91(5):1035-43. PubMed ID: 15116267
[TBL] [Abstract][Full Text] [Related]
13. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
Goto S; Tamura N; Ishida H; Ruggeri ZM
J Am Coll Cardiol; 2006 Jan; 47(1):155-62. PubMed ID: 16386680
[TBL] [Abstract][Full Text] [Related]
14. Relative contributions of collagen and tissue factor to thrombus formation on damaged vascular vessels: in-vitro studies with circulating blood.
Lopez-Vilchez I; Tonda R; Hernandez RM; Navalon F; Diaz-Ricart M; Galan AM; Escolar G
Coron Artery Dis; 2009 Sep; 20(6):392-9. PubMed ID: 19561489
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of thrombosis by a novel platelet selective S-nitrosothiol compound without hemodynamic side effects.
Vilahur G; Baldellou MI; Segalés E; Salas E; Badimon L
Cardiovasc Res; 2004 Mar; 61(4):806-16. PubMed ID: 14985078
[TBL] [Abstract][Full Text] [Related]
16. Antithrombogenic polynitrosated polyester/poly(methyl methacrylate) blend for the coating of blood-contacting surfaces.
Seabra AB; da Silva R; de Souza GF; de Oliveira MG
Artif Organs; 2008 Apr; 32(4):262-7. PubMed ID: 18370938
[TBL] [Abstract][Full Text] [Related]
17. Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers.
Cadroy Y; Thalamas C; Sakariassen K; Boneu B
Thromb Res; 2005; 116(4):293-300. PubMed ID: 16038713
[TBL] [Abstract][Full Text] [Related]
18. Influence of the direct NO-donor SIN-1 on the interaction between platelets and stainless steel stents under dynamic conditions.
Jung F; Mrowietz C; Seyfert UT; Grewe R; Franke RP
Clin Hemorheol Microcirc; 2003; 28(4):189-99. PubMed ID: 12897410
[TBL] [Abstract][Full Text] [Related]
19. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
20. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
